Thrombosis, Venous Clinical Trials Database - Free Access to 10 Studies
Access comprehensive clinical trial information for Thrombosis, Venous through Pure Global AI's free database. This collection includes 10 clinical trials across multiple phases including Phase 3, N/A. Currently, 2 trials are actively recruiting participants.
Research for Thrombosis, Venous is being conducted in Belgium,Canada,Czech,France,Germany,Hungary,Italy,Netherlands,Poland,Russian Federation,Slovenia, Bulgaria,Czech,Estonia,France,Germany,Greece,Hungary,Israel,Italy,Latvia,Netherlands,Poland,Russian , France,Germany,Italy,Netherlands,Russian Federation,Spain and 3+ other countries. Leading sponsors include GlaxoSmithKline and IRCCS San Raffaele. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Venous Thrombosis After Removal of Central Venous Catheter
Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
ARIXTRA® Adherence in SVT Patients.
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
Hemorrhage Risk Prescribed Arixtra
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
Pure Global AI provides free access to 10 clinical trials studying Thrombosis, Venous, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 6+ countries.
Top research sponsors include GlaxoSmithKline, IRCCS San Raffaele, Meir Medical Center, among others.